Member Info for Gunner68

Look at what he did to MGC and when they consolidated and the same happening here absolute shambles time to get a full time CEO in who is respected and has contacts he has been living off one deal .Out of touch and needs to go

GLA

Parker have some balls and either get an RNS out saying joe it is if the trial is still doing well and carnt understand why the sp is dropping like it is and yes you can do it

GLA

Is it a case of P@ss poor planning ?

Damion the BOD should of been forward thinking to get 1802 in tox studies but with no funding imho it has been shelved until we get the money required

Scandalous if you ask me a first in class especially with cancer in mind imagine the interested parties we could have attracted then you only need to see their faces when I asked the Q at the AGM. And the reply given

GLA

Not far from the 30s and if we’re not expecting news till as some say April will we be consolidating again to make us attractive to investors and to stop manipulation of the SP as we did last time ??

Asking for a friend

GLA

Stif you may be right but what you also need to remember is with just over 70m shares upon good news the mms are going to have to raise this a hell of a lot for many shareholders to relinquish their shares just look at the hnwi and at what price they would have to get just to break even along with many others

GLA

Https://www.abpi.org.uk/publications/guidelines-for-phase-i-clinical-trials-2018-edition/

An interesting in depth read

GLA

Nearly 9 months

C@nts

Totally agree scientists in the lab and do we need someone more forward thinking at the helm is it time to start sharpening the pitchfork ?

Remember they work for us the share holders will wait to see what h he append to sp after 1801 news if no good maybe time to call an EGM

GLA

Must be p@sing himself looking at the sp

GLA

Https://endpts.com/bristol-myers-opdivo-fails-part-two-of-post-kidney-cancer-surgery-test-as-competitor-merck-touts-new-survival-data/

Maybe BMS s failure could be a significant opportunity for Sar s 1802 to be resurrected and fully developed in collaboration in the joint targeting of Kidney cancer one of Sar s previously stated targets for SDC 1802 .An option to be considered and get this molecule up and running

GLA

Since the start of the trial we have only dropped 60pc and if some saying no news till March looks like we are only heading one way, looks like puma could be right and we hit the 30s by then . But will we get the big rise s we are hoping to see or just raped by the mms seems amazing how this share is getting mullered on little trading

GLA

See the board buzzing again one day like days of old or like the HE1 board today even though not in is great to see some making money on aim be interesting to see what happens over there the next few days and what impact on Sar once we have the next RNS ref 1801 even 737 could see us move on a decent up front payment once things get moving

GLA

Question 10:

Assuming the Board has a strategy in place for the commercialisation of SDC-1801, could you outline some of the factors taken into consideration during the planning?

Our Board has conducted market research to identify which companies are most likely to consider in-licensing a product such as SDC-1801 and to understand the strengths and weaknesses of our competitors. We also have a continued dialogue with potential partners to understand what they need to see in a data package before committing to a licensing deal.

GLA

SAD will the food phase of the trial continue with the MAD and do you know at what point it may finish ? Could this go on for another couple of months

TIA

Gla

Hi PCS Hassan and Pascal both seem like people who can muster interest and possible more funding looks like we just need the Data Data Date and hopefully we will take off from there .have a great weekend just waiting for the red dot to land now

GLA

Https://www.fiercebiotech.com/biotech/cgs-and-arrivents-oversized-ipos-bode-well-2024-after-dreary-year

GLA

Https://www.fiercebiotech.com/biotech/saudi-arabia-launches-plan-become-biotech-hub-2040

Maybe we should be looking at funding from this part of the world especially if 1801 comes up trumps

GLA

Hi August it would be great to see movement on 1802 full stop as long as we see it going forward I’m sure would make everyone happy and add value to the SP hopefully being first in class ,interesting times ahead with 1801/737

GLA